The U.S. Food and Drug Administration approved the pill version of Wegovy on December 22, marking the first FDA-approved ...
A popular weight loss drug made in the Triangle is now available in pill form. On Monday, pharmaceutical company Novo Nordisk ...
The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
The FDA has fast-tracked six therapies since December 2025 through its priority review and National Priority Voucher programs, including the first approval issued under the agency’s new pilot pathway.
Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.
46 new molecular entities cleared the agency’s hurdles last year, 4 fewer than in 2024 ...
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly ...
The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.
The US saw several new and expanded FDA indications this year. The top 5 most-read FDA approvals on AJMC.com included 4 novel ...
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law LOS ANGELES, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results